Nektar Therapeutics
NKTR· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $28.51M | $33.86M | $23.68M | $17.33M |
| Net Income | -$32.64M | -$42.75M | -$34.29M | -$36.38M |
| EPS Diluted | -$0.26 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.37 |
| -$0.30 |
| -$0.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.